Publications: Mrs Joanne Haviland

Haviland J ( 2023 ) . Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial . The Lancet Oncology

Haviland J ( 2023 ) . One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT . Health Technology Assessment vol. 27 , ( 25 )

Hill M, Iro M, Sadarangani M, Absoud M, Cantrell L, Chong K, Clark C, Easton A et al. ( 2023 ) . Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial . BMJ Open vol. 13 , ( 11 )

Hudson EM, Slevin F, Biscombe K, Brown SR, Haviland JS, Murray L, Kirby AM, Thomson DJ et al. ( 2023 ) . Hitting the Target: Developing High-quality Evidence for Proton Beam Therapy Through Randomised Controlled Trials . Clinical Oncology vol. 36 , ( 2 ) 70 - 79 .

Brunt AM, Haviland JS, Wheatley DA, Sydenham MA, Bloomfield DJ, Chan C, Cleator S, Coles CE et al. ( 2023 ) . One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT . Health Technology Assessment vol. 27 , ( 25 ) 1 - 176 .

Philipps L, Foster S, Gardiner D, Gath J, Gillman A, Haviland J, Hill E, King D et al. ( 2023 ) . Study within a trial of electronic versus paper-based Patient-Reported oUtcomes CollEction (SPRUCE): study protocol for a partially randomised patient preference study . BMJ Open vol. 13 , ( 9 )

Haviland J ( 2023 ) . Should patients requiring radiotherapy for breast cancer be treated with proton beam therapy? . British Medical Journal

Haviland J ( 2023 ) . Dose escalated simultaneous integrated boost radiotherapy in early breast cancer: results of the 1 IMPORT HIGH multi-centre phase III randomised controlled trial (ISRCTN47437448) . The Lancet

Brunt AM, Haviland JS ( 2023 ) . Hypofractionation: The standard for external beam breast irradiation . The Breast vol. 69 , 410 - 416 .

Holt F, Probert J, Darby S, Haviland JS, Coles CE, Kirby AM, Liu Z, Dodwell D et al. ( 2023 ) . Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes . International Journal of Radiation Oncology • Biology • Physics vol. 117 , ( 4 ) 869 - 882 .

Kirby AM, Haviland JS, Mackenzie M, Fleming H, Anandadas C, Wickers S, Miles E, Iles N et al. ( 2023 ) . Proton Beam Therapy in Breast Cancer Patients: The UK PARABLE Trial is Recruiting . Clinical Oncology vol. 35 , ( 6 ) 347 - 350 .

Philipps L, Foster S, Gardiner D, Gillman A, Haviland J, Hill E, Manning G, Stiles M et al. ( 2022 ) . Considerations when introducing electronic patient-reported outcome data capture in multicentre oncology randomised controlled trials . Trials vol. 23 , ( 1 )

Glynn D, Bliss J, Brunt AM, Coles CE, Wheatley D, Haviland JS, Kirby AM, Longo F et al. ( 2022 ) . Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis . Breast Cancer Research and Treatment vol. 197 , ( 2 ) 405 - 416 .

Holt F, Probert J, Liu Z, Duane F, Ntentas G, Darby S, Dodwell D, Coles C et al. ( 2022 ) . 146 (PB-059) Poster Proton beam therapy for early breast cancer: a systematic review and quantitative synthesis of adverse clinical outcomes . European Journal of Cancer . vol. 175 , s46 - s47 .

Underwood TSA, McNamara AL, Appelt A, Haviland JS, Sørensen BS, Troost EGC ( 2022 ) . A systematic review of clinical studies on variable proton Relative Biological Effectiveness (RBE) . Radiotherapy and Oncology vol. 175 , 79 - 92 .

Barnett GC, Kerns SL, Dorling L, Fachal L, Aguado-Barrera ME, Martínez-Calvo L, Jandu HK, Welsh C et al. ( 2022 ) . No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity . International Journal of Radiation Oncology • Biology • Physics vol. 114 , ( 3 ) 494 - 501 .

Ranger A, Dunlop A, Hansen VN, Princewill G, Landeg S, Donovan EM, Harris EJ, McNair HA et al. ( 2022 ) . A Randomised Phase II Clinical Trial Comparing the Deliverability and Acute Toxicity of Wide Tangent versus Volumetric Modulated Arc Therapy to the Breast and Internal Mammary Chain . Clinical Oncology vol. 34 , ( 8 ) 526 - 533 .

Wheatley D, Haviland J, Patel J, Sydenham M, Alhasso A, Chan C, Cleator S, Coles C et al. ( 2022 ) . OC-0101 First results of FAST-Forward phase 3 RCT nodal substudy: 3-year normal tissue effects . Radiotherapy and Oncology . vol. 170 , s75 - s76 .

Staffurth JN, Haviland JS, Wilkins A, Syndikus I, Khoo V, Bloomfield D, Parker C, Logue J et al. ( 2021 ) . Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016) . European Urology Oncology vol. 4 , ( 6 ) 980 - 992 .

Coles C, Haviland JS, Kirby AM, Bhattacharya I, Brunt AM, Chan C, Donovan EM, Eaton DJ et al. ( 2021 ) . OC-0291 IMPORT HIGH trial: Dose escalated simultaneous integrated boost radiotherapy in early breast cancer . Radiotherapy and Oncology . vol. 161 , s197 - s199 .

Robinson R, Haviland JS ( 2021 ) . Understanding Statistical Significance and Avoiding Common Pitfalls . Clinical Oncology vol. 33 , ( 12 ) 804 - 806 .

Bhattacharya IS, Haviland JS, Turner L, Stobart H, Balasopoulou A, Stones L, Kirby AM, Kirwan CC et al. ( 2021 ) . Can patient decision aids reduce decisional conflict in a de-escalation of breast radiotherapy clinical trial? The PRIMETIME Study Within a Trial implemented using a cluster stepped-wedge trial design . Trials vol. 22 , ( 1 )

Obeng-Gyasi S, Coles CE, Jones J, Sacks R, Lightowlers S, Bliss JM, Brunt AM, Haviland JS et al. ( 2021 ) . When the World Throws You a Curve Ball: Lessons Learned in Breast Cancer Management . American Society of Clinical Oncology Educational Book vol. 41 , ( 41 ) 1 - 11 .

Brunt AM, Haviland JS, Kirby AM, Somaiah N, Wheatley DA, Bliss JM, Yarnold JR ( 2021 ) . Five-fraction Radiotherapy for Breast Cancer: FAST-Forward to Implementation . Clinical Oncology vol. 33 , ( 7 ) 430 - 439 .

Coles C, Haviland JS, Kirby AM, Bhattacharya I, Brunt AM, Chan C, Donovan EM, Eaton DJ et al. ( 2021 ) . IMPORT HIGH trial: Dose escalated simultaneous integrated boost radiotherapy in early breast cancer . RADIOTHERAPY AND ONCOLOGY . vol. 161 , S197 - S199 .

Coles CE, Haviland JS, Kirby AM ( 2020 ) . Internal mammary node irradiation in breast cancer: does benefit outweigh risk? . The Lancet Oncology vol. 21 , ( 12 ) 1541 - 1543 .

Brunt AM, Haviland JS, Wheatley DA, Yarnold JR ( 2020 ) . Breast cancer radiation therapy – Authors' reply . The Lancet vol. 396 , ( 10262 ) 1559 - 1560 .

Brunt AM, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield D, Chan C, Churn M et al. ( 2020 ) . OC-0610: FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 5-year results . Radiotherapy and Oncology . vol. 152 , s346 - s347 .

Bentzen SM, Haviland JS, Yarnold JR ( 2020 ) . Targeted Intraoperative Radiotherapy for Early Breast Cancer . JAMA Oncology vol. 6 , ( 10 ) 1636 - 1636 .

Brunt AM, Haviland JS, Sydenham M, Agrawal RK, Algurafi H, Alhasso A, Barrett-Lee P, Bliss P et al. ( 2020 ) . Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer . Journal of Clinical Oncology vol. 38 , ( 28 ) 3261 - 3272 .

Brunt AM, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, Chan C, Churn M et al. ( 2020 ) . Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial . The Lancet vol. 395 , ( 10237 ) 1613 - 1626 .

Bhattacharya IS, Haviland J, Balasopoulou A, Stones L, Stobart H, Turner L, Hopwood P, Coles CE et al. ( 2020 ) . Abstract P6-12-04: Does the addition of a patient decision aid video reduce decisional conflict in patients considering a de-escalation of radiotherapy trial? Results from the PRIMETIME study . Cancer Research . vol. 80 ,

Bhattacharya IS, Haviland JS, Balasopoulou A, Stones L, Stobart H, Turner L, Hopwood P, Bliss JM et al. ( 2020 ) . Abstract P6-12-10: Method development for a ‘Study within a Trial’ using a cluster stepped wedge trial design: Evaluating a patient decision aid video on patients’ decisional conflict in the PRIMETIME study . Cancer Research . vol. 80 ,

Brunt AM, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield D, Chan C, Churn M et al. ( 2020 ) . FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 5-year results . RADIOTHERAPY AND ONCOLOGY . vol. 152 , S346 - S347 .

Beeken RJ, Haviland JS, Taylor C, Campbell A, Fisher A, Grimmett C, Ozakinci G, Slater S et al. ( 2019 ) . Smoking, alcohol consumption, diet and physical activity following stoma formation surgery, stoma-related concerns, and desire for lifestyle advice: a United Kingdom survey . BMC Public Health vol. 19 , ( 1 )

Bhattacharya IS, Haviland JS, Perotti C, Eaton D, Gulliford S, Harris E, Coles CE, Kirwan CC et al. ( 2019 ) . Is breast seroma after tumour resection associated with patient-reported breast appearance change following radiotherapy? Results from the IMPORT HIGH (CRUK/06/003) trial . Radiotherapy and Oncology vol. 136 , 190 - 196 .

Bhattacharya IS, Haviland JS, Perotti C, Eaton D, Gulliford S, Harris E, Coles CE, Kirwan CC et al. ( 2019 ) . OC-0595 Does seroma predict patient-reported adverse effects following breast radiotherapy in IMPORT HIGH? . Radiotherapy and Oncology . vol. 133 ,

Bhattacharya IS, Haviland JS, Hopwood P, Coles CE, Yarnold JR, Bliss JM, Kirby AM, Trialists I ( 2019 ) . Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial . Radiotherapy and Oncology vol. 134 , 220 - 230 .

Coles C, Griffin C, Kirby A, Haviland J, Titley J, Benstead K, Brunt A, Chan C et al. ( 2019 ) . Abstract GS4-05: Dose escalated simultaneous integrated boost radiotherapy for women treated by breast conservation surgery for early breast cancer: 3-year adverse effects in the IMPORT HIGH trial (CRUK/06/003) . Cancer Research . vol. 79 ,

Bhattacharya IS, Haviland JS, Kirby AM, Kirwan CC, Hopwood P, Yarnold JR, Bliss JM, Coles CE ( 2018 ) . Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial . Journal of Clinical Oncology vol. 37 , ( 4 ) 305 - 317 .

Brunt AM, Haviland J, Sydenham M, Algurafi H, Alhasso A, Bliss P, Bloomfield D, Emson M et al. ( 2018 ) . FAST Phase III RCT of Radiotherapy Hypofractionation for Treatment of Early Breast Cancer: 10-Year Results (CRUKE/04/015) . International Journal of Radiation Oncology • Biology • Physics . vol. 102 , 1603 - 1604 .

Staffurth J, Haviland J, Wilkins A, Syndikus I, Khoo V, Bloomfield D, Parker C, Logue J et al. ( 2018 ) . Impact of Prostate Cancer Hypofractionation on Patient Reported Outcomes: Baseline to 5 Years Change in the CHHIP Trial . International Journal of Radiation Oncology • Biology • Physics . vol. 102 , s1 - s2 .

Kirby AM, Bhattacharya IS, Wilcox M, Haviland JS ( 2018 ) . The IMPORT LOW Trial: Collaborative Research Accelerates Practice Change in Breast Radiotherapy . Clinical Oncology vol. 31 , ( 1 ) 5 - 8 .

Batten LM, Bhattacharya IS, Moretti L, Haviland JS, Emson MA, Miller SE, Jefford M, MacKenzie M et al. ( 2018 ) . Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies . Research Involvement and Engagement vol. 4 , ( 1 )

Fenlon D, Nuttall J, May C, Raftery J, Fields J, Kirkpatrick E, Abab J, Ellis M et al. ( 2018 ) . MENOS4 trial: a multicentre randomised controlled trial (RCT) of a breast care nurse delivered cognitive behavioural therapy (CBT) intervention to reduce the impact of hot flushes in women with breast cancer: Study Protocol . BMC Women's Health vol. 18 , ( 1 )

Mills J, Haviland JS, Moynihan C, Bliss JM, Hopwood P, Group TSTM ( 2018 ) . Women's Free-text Comments on their Quality of Life: An Exploratory Analysis from the UK Standardisation of Breast Radiotherapy (START) Trials for Early Breast Cancer . Clinical Oncology vol. 30 , ( 7 ) 433 - 441 .

Bhattacharya IS, Haviland JS, Hopwood P, Kirby AM, Yarnold JR, Bliss JM, Coles CE ( 2018 ) . 3 A longitudinal analysis of patient reported outcomes over 5 years in the IMPORT LOW (partial breast radiotherapy after breast conservation surgery) phase III randomised controlled trial . European Journal of Cancer vol. 92 ,

Bhattacharya IS, Haviland JS, Kirby AM, Hopwood P, Yarnold JR, Bliss JM, Coles CE ( 2018 ) . OC-0156: Concordance of patient reported outcomes with clinician and photographic assessments in IMPORT LOW . Radiotherapy and Oncology . vol. 127 ,

Brunt AM, Haviland J, Sydenham M, Al-hasso A, Bloomfield D, Chan C, Churn M, Cleator S et al. ( 2018 ) . OC-0595: FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy:3-year normal tissue effects . Radiotherapy and Oncology . vol. 127 , s311 - s312 .

Grimmett C, Haviland J, Winter J, Calman L, Din A, Richardson A, Smith PWF, Foster C ( 2018 ) . Self-efficacy for managing illness-related problems; results from the ColoREctal Wellbeing (CREW) study . European Journal of Surgical Oncology vol. 44 ,

Wilkins A, Gusterson B, Szijgyarto Z, Haviland J, Griffin C, Stuttle C, Daley F, Corbishley CM et al. ( 2018 ) . Assessment of Ki67 in relation to radiotherapy (RT) fractionation and prognosis in the CHHiP (CRUK/06/016) trial . Journal of Clinical Oncology . vol. 36 , 98 - 98 .

Wilkins AC, Gusterson B, Szijgyarto Z, Haviland J, Griffin C, Stuttle C, Daley F, Corbishley CM et al. ( 2018 ) . Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer . International Journal of Radiation Oncology • Biology • Physics vol. 101 , ( 2 ) 309 - 315 .

Bhattacharya IS, Haviland JS, Hopwood P, Kirby AM, Yarnold JR, Bliss JM, Coles CE ( 2018 ) . A longitudinal analysis of patient reported outcomes over 5 years in the IMPORT LOW (partial breast radiotherapy after breast conservation surgery) phase III randomised controlled trial . EUROPEAN JOURNAL OF CANCER . vol. 92 , S8 - S8 .

Brunt AM, Haviland J, Sydenham M, Alhasso A, Bloomfield D, Chan C, Churn M, Cleator S et al. ( 2018 ) . FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 3-year normal tissue effects . BRITISH JOURNAL OF CANCER . vol. 119 , 41 - 41 .

Coles CE, Haviland JS, Kirby AM, Titley J, Wilcox M, Bliss JM, Yarnold JR ( 2018 ) . Targeted radiotherapy for early breast cancer – Authors' reply . The Lancet vol. 391 , ( 10115 ) 27 - 28 .

Haviland JS, Mannino M, Griffin C, Porta N, Sydenham M, Bliss JM, Yarnold JR, Group TST ( 2017 ) . Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials . Radiotherapy and Oncology vol. 126 , ( 1 ) 155 - 162 .

Grimmett C, Haviland J, Winter J, Calman L, Din A, Richardson A, Smith PWF, Foster C ( 2017 ) . Self-efficacy for managing illness-related problems; results from the ColoREctal Wellbeing (CREW) study . European Journal of Surgical Oncology vol. 43 , ( 11 )

Haviland J, Sodergren S, Calman L, Corner J, Din A, Fenlon D, Grimmett C, Richardson A et al. ( 2017 ) . Social support following diagnosis and treatment for colorectal cancer and associations with health‐related quality of life: Results from the UK ColoREctal Wellbeing (CREW) cohort study . Psycho-Oncology vol. 26 , ( 12 ) 2276 - 2284 .

Grimmett C, Haviland J, Winter J, Calman L, Din A, Richardson A, Smith PWF, Foster C ( 2017 ) . Colorectal cancer patient’s self-efficacy for managing illness-related problems in the first 2 years after diagnosis, results from the ColoREctal Well-being (CREW) study . Journal of Cancer Survivorship vol. 11 , ( 5 ) 634 - 642 .

Coles CE, Griffin CL, Kirby AM, Titley J, Agrawal RK, Alhasso A, Bhattacharya IS, Brunt AM et al. ( 2017 ) . Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial . The Lancet vol. 390 , ( 10099 ) 1048 - 1060 .

Coles C, Griffin C, Kirby A, Agrawal R, Alhasso A, Bhattacharya I, Brunt AM, Ciurlionis L et al. ( 2017 ) . SP-0314: Partial breast radiotherapy after breast conservation: 5 year outcomes from the IMPORT LOW (CRUK/06/003) phase III trial . Radiotherapy and Oncology . vol. 123 , s162 - s163 .

Bartlett FR, Donovan EM, McNair HA, Corsini LA, Colgan RM, Evans PM, Maynard L, Griffin C et al. ( 2016 ) . The UK HeartSpare Study (Stage II): Multicentre Evaluation of a Voluntary Breath-hold Technique in Patients Receiving Breast Radiotherapy . Clinical Oncology vol. 29 , ( 3 ) e51 - e56 .

Haviland J, Cummings A, Winter J, Grimmett C, Calman L, Corner J, Din A, Fenlon D et al. ( 2016 ) . The impact of co-morbidities on recovery from colorectal cancer within first 2 years after surgery: Results from the UK Colorectal Wellbeing (CREW) cohort study . European Journal of Surgical Oncology vol. 42 , ( 11 )

Haviland JS, Bentzen SM, Bliss JM, Yarnold JR, Group STM ( 2016 ) . Prolongation of overall treatment time as a cause of treatment failure in early breast cancer: An analysis of the UK START (Standardisation of Breast Radiotherapy) trials of radiotherapy fractionation . Radiotherapy and Oncology vol. 121 , ( 3 ) 420 - 423 .

Haviland J, Yarnold J, Bliss J, Hopwood P, Wilcox M ( 2016 ) . Reply to Goodare et al. Re: Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? . Clinical Oncology vol. 28 , ( 10 ) 665 - 666 .

Skilbeck J, Corner J, Bath P, Beech N, Clark D, Hughes P, Douglas H-R, Halliday D et al. ( 2016 ) . Clinical nurse specialists in palliative care. Part 1. A description of the Macmillan Nurse caseload . Palliative Medicine vol. 16 , ( 4 ) 285 - 296 .

Clark D, Seymour J, Douglas H-R, Bath P, Beech N, Corner J, Halliday D, Hughes P et al. ( 2016 ) . Clinical nurse specialists in palliative care. Part 2. Explaining diversity in the organization and costs of Macmillan nursing services . Palliative Medicine vol. 16 , ( 5 ) 375 - 385 .

Seymour J, Clark D, Hughes P, Bath P, Beech N, Corner J, Douglas H-R, Halliday D et al. ( 2016 ) . Clinical nurse specialists in palliative care. Part 3. Issues for the Macmillan Nurse role . Palliative Medicine vol. 16 , ( 5 ) 386 - 394 .

Krishnasamy M, Wilkie E, Haviland J ( 2016 ) . Lung cancer health care needs assessment: patients' and informal carers' responses to a national mail questionnaire survey . Palliative Medicine vol. 15 , ( 3 ) 213 - 227 .

Foster C, Haviland J, Winter J, Grimmett C, Chivers Seymour K, Batehup L, Calman L, Corner J et al. ( 2016 ) . Pre-Surgery Depression and Confidence to Manage Problems Predict Recovery Trajectories of Health and Wellbeing in the First Two Years following Colorectal Cancer: Results from the CREW Cohort Study . PLOS ONE vol. 11 , ( 5 )

Haviland JS, Hopwood P, Mills J, Sydenham M, Bliss JM, Yarnold JR, Group ST ( 2016 ) . Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? The Experience of the Standardisation of Breast Radiotherapy (START) Trials in Early Breast Cancer . Clinical Oncology vol. 28 , ( 6 ) 345 - 353 .

Juneja P, Bonora M, Haviland JS, Harris E, Evans P, Somaiah N ( 2016 ) . Does breast composition influence late adverse effects in breast radiotherapy? . The Breast vol. 26 , 25 - 30 .

Harris EJ, Mukesh MB, Donovan EM, Kirby AM, Haviland JS, Jena R, Yarnold J, Baker A et al. ( 2015 ) . A multicentre study of the evidence for customized margins in photon breast boost radiotherapy . British Journal of Radiology vol. 89 , ( 1058 )

Haviland JS, Bliss JM, Bentzen SM, Cuzick J ( 2015 ) . In Regard to Vaidya et al . International Journal of Radiation Oncology • Biology • Physics vol. 92 , ( 5 ) 954 - 955 .

Bartlett FR, Donovan EM, McNair HA, Corsini L, Griffin C, Colgan RM, Haviland JS, Evans PM et al. ( 2015 ) . OC-0387: The UK HeartSpare Study (Stage II): Multicentre evaluation of a voluntary breath-hold technique . Radiotherapy and Oncology vol. 115 ,

Bartlett FR, Donovan EM, McNair HA, Corsini L, Griffin C, Colgan RM, Haviland JS, Evans PM et al. ( 2015 ) . The UK HeartSpare Study (Stage II): Multicentre evaluation of a voluntary breath-hold technique . RADIOTHERAPY AND ONCOLOGY . vol. 115 , S186 - S186 .

Bartlett FR, Colgan RM, Donovan EM, McNair HA, Carr K, Evans PM, Griffin C, Locke I et al. ( 2014 ) . The UK HeartSpare Study (Stage IB): Randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery . Radiotherapy and Oncology vol. 114 , ( 1 ) 66 - 72 .

Harris EJ, Mukesh M, Jena R, Baker A, Bartelink H, Brooks C, Dean J, Donovan EM et al. ( 2014 ) . Evaluation of Image Guided Radiotherapy for more accurate Partial Breast Intensity-Modulated Radiotherapy: comparison with standard imaging technique . Efficacy and Mechanism Evaluation vol. 1 , ( 3 ) 1 - 74 .

Donovan EM, Harris EJ, Mukesh MB, Haviland JS, Titley J, Griffin C, Coles CE, Evans PM et al. ( 2014 ) . The IMPORT HIGH Image-guided Radiotherapy Study: A Model for Assessing Image-guided Radiotherapy . Clinical Oncology vol. 27 , ( 1 ) 3 - 5 .

Kaidar-Person O, Poortmans P, Klimberg S, Haviland J, Offersen B, Audisio R, Yarnold J ( 2014 ) . Haste makes waste: Are the data regarding TARGIT-A IORT ready for prime time? . Breast Cancer Research and Treatment vol. 147 , ( 1 ) 221 - 222 .

Bartlett FR, Colgan RM, Donovan EM, Carr K, Landeg S, Clements N, McNair HA, Locke I et al. ( 2014 ) . Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy . Journal of Visualized Experiments ( 89 )

Haviland JS, A'Hern R, Bentzen SM, Whelan T, Bliss JM ( 2014 ) . Radiotherapy for breast cancer, the TARGIT-A trial . The Lancet vol. 383 , ( 9930 ) 1716 - 1717 .

Westbury CB, Haviland J, Davies S, Gothard L, Abdi BA, Sydenham M, Bowen J, Stratton R et al. ( 2014 ) . Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapy . Radiation Oncology vol. 9 , ( 1 )

Barnett GC, Thompson D, Fachal L, Kerns S, Talbot C, Elliott RM, Dorling L, Coles CE et al. ( 2014 ) . A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity . Radiotherapy and Oncology vol. 111 , ( 2 ) 178 - 185 .

Haviland JS, Bliss JM, Sydenham M, Yarnold JR ( 2014 ) . Late effects of breast radiotherapy . The Lancet vol. 383 , ( 9926 ) 1383 - 1384 .

Venables K, Miles EA, Aird EGA, Hoskin PJ ( 2014 ) . What is the optimum breast plan: a study based on the START trial plans . British Journal of Radiology vol. 79 , ( 945 ) 734 - 739 .

Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, Dobbs HJ, Hopwood P et al. ( 2013 ) . The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials . The Lancet Oncology vol. 14 , ( 11 ) 1086 - 1094 .

Mukesh MB, Harris E, Collette S, Coles CE, Bartelink H, Wilkinson J, Evans PM, Graham P et al. ( 2013 ) . Normal tissue complication probability (NTCP) parameters for breast fibrosis: Pooled results from two randomised trials . Radiotherapy and Oncology vol. 108 , ( 2 ) 293 - 298 .

Bartlett FR, Colgan RM, Carr K, Donovan EM, McNair HA, Locke I, Evans PM, Haviland JS et al. ( 2013 ) . The UK HeartSpare Study: Randomised evaluation of voluntary deep-inspiratory breath-hold in women undergoing breast radiotherapy . Radiotherapy and Oncology vol. 108 , ( 2 ) 242 - 247 .

Mukesh MB, Harris E, Collette S, Coles CE, Bartelink H, Haviland J, Poortmans P, Evans PM et al. ( 2013 ) . OC-0075: Normal tissue complication probability parameters for breast fibrosis: pooled results from two randomised trials . Radiotherapy and Oncology vol. 106 ,

Yarnold J, Haviland J, Bentzen SM, Sydenham M, Owen R, Bliss J ( 2013 ) . Estimation of an overall treatment time factor for local relapse after adjuvant radiotherapy for early breast cancer by the UK START Trialists' Group . EUROPEAN JOURNAL OF CANCER . vol. 49 , S405 - S406 .

Bartlett F, Donovan E, Colgan R, McNair H, Carr K, Locke I, Evans P, Haviland J et al. ( 2013 ) . Partial breast irradiation margins with two deep-inspiratory breath-hold techniques . EUROPEAN JOURNAL OF CANCER . vol. 49 , S235 - S235 .

Rodrigues D, Somaiah N, Daley F, Davies S, Rakha E, A'Hern R, Haviland J, Sydenham M et al. ( 2012 ) . Abstract P3-06-09: Test of association between Ki67 index of early breast cancer and local relapse after adjuvant hypofractionated radiotherapy . Cancer Research . vol. 72 ,

Haviland J, Agrawal R, Aird E, Barrett J, Barrett-Lee P, Brown J, Dewar J, Dobbs J et al. ( 2012 ) . Abstract S4-1: The UK START (Standardisation of Breast Radiotherapy) Trials: 10-year follow-up results . Cancer Research . vol. 72 ,

Andreassen CN, Barnett GC, Langendijk JA, Alsner J, De Ruysscher D, Krause M, Bentzen SM, Haviland JS et al. ( 2012 ) . Conducting radiogenomic research – Do not forget careful consideration of the clinical data . Radiotherapy and Oncology vol. 105 , ( 3 ) 337 - 340 .

Coles CE, Donovan E, Haviland J, Yarnold J ( 2012 ) . Intensity-modulated Radiotherapy for the Treatment of Breast Cancer . Clinical Oncology vol. 25 , ( 3 )

Winters ZE, Haviland J, Balta V, Benson J, Reece‐Smith A, Betambeau N, Group TPTM ( 2012 ) . Integration of patient‐reported outcome measures with key clinical outcomes after immediate latissimus dorsi breast reconstruction and adjuvant treatment . British Journal of Surgery vol. 100 , ( 2 ) 240 - 251 .

Watson M, Homewood J, Haviland J ( 2012 ) . Coping Response and Survival in Breast Cancer Patients: A New Analysis . Stress and Health vol. 28 , ( 5 ) 376 - 380 .

Tsang Y, Haviland J, Venables K, Yarnold J, Group OBOTFTM ( 2012 ) . The impact of dose heterogeneity on late normal tissue complication risk after hypofractionated whole breast radiotherapy . Radiotherapy and Oncology vol. 104 , ( 2 ) 143 - 147 .

Winters Z, Mills J, Haviland J, Reece-Smith A, Greenslade M, Galea M, McManus P, Nicholson S et al. ( 2012 ) . A Multi centre prospective longitudinal study evaluating the integration of Patient Reported Outcomes (PROMS) with key clinical outcomes after immediate Latissimus dorsi (LD) breast reconstruction and adjuvant treatment . European Journal of Surgical Oncology vol. 38 , ( 5 )

Westbury CB, Davies S, Haviland J, Gothard L, Bowen J, Stratton R, Short S, Yarnold JR ( 2012 ) . EP-1575 INVESTIGATION OF INTERLEUKIN 6 AS A BIOMARKER OF RADIATION FIBROSIS IN BREAST CANCER . Radiotherapy and Oncology vol. 103 ,

Haviland JS, Sydenham M, Mills J, Hopwood P, Bliss JM, Yarnold JR ( 2012 ) . OC-0135 CAN PATIENT REPORTED OUTCOME MEASURES REPLACE CLINICAL ASSESSMENTS IN BREAST RADIOTHERAPY TRIALS? . Radiotherapy and Oncology vol. 103 ,

Tsang Y, Venables K, Yarnold J ( 2012 ) . Quality assurance analysis of participating centres’ protocol compliance to a UK multicentre hypofractionated breast (FAST) trial . British Journal of Radiology vol. 85 , ( 1017 ) e647 - e653 .

Winters Z, Haviland J, Reece-Smith A, Betambeau N, Choudhry K, Chaudhry A, Mills J, Benson J et al. ( 2011 ) . P2-16-01: A Multi-Centre Prospective Cohort Study Evaluating Health Related Quality of Life after Types of Immediate Latissimus Dorsi (LD) Breast Reconstruction . Cancer Research . vol. 71 ,

Gothard L, Haviland J, Bryson P, Laden G, Glover M, Harrison S, Woods M, Cook G et al. ( 2011 ) . Randomised phased II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema after radiotherapy for cancer . Vasomed vol. 23 , ( 6 ) 302 - 303 .

Reed E, Simmonds P, Haviland J, Corner J ( 2011 ) . Quality of Life and Experience of Care in Women With Metastatic Breast Cancer: A Cross-Sectional Survey . Journal of Pain and Symptom Management vol. 43 , ( 4 ) 747 - 758 .

Agrawal RK, Alhasso A, Barrett-Lee PJ, Bliss JM, Bliss P, Bloomfield D, Bowen J, Brunt AM et al. ( 2011 ) . First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015) . Radiotherapy and Oncology vol. 100 , ( 1 ) 93 - 100 .

Westbury C, Davies S, Haviland J, Gothard L, Stratton R, Short S, Yarnold JR ( 2011 ) . 911 poster BIOMARKERS OF RADIATION FIBROSIS IN BREAST CANCER: A METHODS VALIDATION STUDY FOR INTERLEUKIN 6 . Radiotherapy and Oncology . vol. 99 ,

Yarnold JR, Owen R, Haviland J ( 2011 ) . VOLUME EFFECTS FOR LATE ADVERSE EFFECTS AFTER ADJUVANT BREAST RADIOTHERAPY . Radiotherapy and Oncology . vol. 98 ,

Goldsmith C, Haviland J, Tsang Y, Sydenham M, Yarnold J, Group OBOTFT ( 2011 ) . Large breast size as a risk factor for late adverse effects of breast radiotherapy: Is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation? . Radiotherapy and Oncology vol. 100 , ( 2 ) 236 - 240 .

Gothard L, Haviland J, Bryson P, Laden G, Glover M, Harrison S, Woods M, Cook G et al. ( 2011 ) . Corrigendum to “Randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema after radiotherapy for cancer” [Radiother Oncol 97 (2010) 101–107] . Radiotherapy and Oncology vol. 98 , ( 2 )

Yarnold J, Haviland J ( 2010 ) . Hypofractionated Adjuvant Whole Breast Radiotherapy: Progress and Prospects . Acta Oncologica vol. 49 , ( 8 ) 1288 - 1292 .

Yarnold J, Bentzen SM, Coles C, Haviland J ( 2010 ) . Hypofractionated Whole-Breast Radiotherapy for Women With Early Breast Cancer: Myths and Realities . International Journal of Radiation Oncology • Biology • Physics vol. 79 , ( 1 ) 1 - 9 .

Haviland JS, A'Hern R, Bliss JM ( 2010 ) . Intraoperative radiotherapy for early breast cancer . The Lancet vol. 376 , ( 9747 )

Martin S, Sydenham M, Haviland J, A’Hern R, Owen R, Bliss J, Yarnold J ( 2010 ) . Test of association between variant tgβ1 alleles and late adverse effects of breast radiotherapy . Radiotherapy and Oncology vol. 97 , ( 1 ) 15 - 18 .

Winters ZE, Mills J, Haviland J, Reece-Smith A, Greenslade M, Benson J, Galea M, McManus P et al. ( 2010 ) . O-92 A multi centre prospective longitudinal study evaluating health related quality of life after immediate Latissimus dorsi (LD) breast reconstruction . European Journal of Cancer Supplements . vol. 8 , 34 - 35 .

Haviland JS, Hopwood P, Mills J, Bliss JM, Yarnold JR, Group OBOTSTM ( 2010 ) . Quality of life after breast radiotherapy – Authors' reply . The Lancet Oncology vol. 11 , ( 7 ) 612 - 613 .

Kirby AM, Evans PM, Donovan EM, Convery HM, Haviland JS, Yarnold JR ( 2010 ) . Prone versus supine positioning for whole and partial-breast radiotherapy: A comparison of non-target tissue dosimetry . Radiotherapy and Oncology vol. 96 , ( 2 ) 178 - 184 .

Yarnold J, Haviland J ( 2010 ) . Pushing the limits of hypofractionation for adjuvant whole breast radiotherapy . The Breast vol. 19 , ( 3 ) 176 - 179 .

Gothard L, Haviland J, Bryson P, Laden G, Glover M, Harrison S, Woods M, Cook G et al. ( 2010 ) . Randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema after radiotherapy for cancer . Radiotherapy and Oncology vol. 97 , ( 1 ) 101 - 107 .

Haviland JS, Yarnold JR, Bentzen SM ( 2010 ) . Hypofractionated Radiotherapy for Breast Cancer . New England Journal of Medicine vol. 362 , ( 19 ) 1843 - 1844 .

Gujral DM, Sumo G, Owen JR, Ashton A, Bliss JM, Haviland J, Yarnold JR ( 2010 ) . Ipsilateral Breast Tumor Relapse: Local Recurrence Versus New Primary Tumor and the Effect of Whole-Breast Radiotherapy on the Rate of New Primaries . International Journal of Radiation Oncology • Biology • Physics vol. 79 , ( 1 ) 19 - 25 .

Winters Z, Haviland J, Mills J, Benson J, Galea M, McManus P, Nicholson S, Weiler-Mithoff E et al. ( 2010 ) . 378 A multicentre prospective longitudinal study establishing level II evidence of health related quality of life after types of immediate latissimus dorsi (LD) breast reconstruction . European Journal of Cancer Supplements . vol. 8 ,

Hopwood P, Haviland JS, Sumo G, Mills J, Bliss JM, Yarnold JR, Group OBOTSTM ( 2010 ) . Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials . The Lancet Oncology vol. 11 , ( 3 ) 231 - 240 .

Hopwood P, Sumo G, Mills J, Haviland J, Bliss JM, Group OBOTSTM ( 2009 ) . The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: Results from the UK Standardisation of Radiotherapy Trials (START) . The Breast vol. 19 , ( 2 ) 84 - 91 .

Winters Z, Mills J, Haviland J, Reece-Smith A, Greenslade M, Benson J, Galea M, MacMannus P et al. ( 2009 ) . A Multi Centre Prospective Longitudinal Study Establishing Level II Evidence of Health Related Quality of Life after Types of Immediate Latissimus Dorsi (LD) Breast Reconstruction . Cancer Research vol. 69 , ( 24_Supplement ) 3106 - 3106 .

Thomson H, Mills J, Haviland J, Smith AR, Greenslade M, Benson J, Galea M, McManus P et al. ( 2009 ) . A multi centre prospective longitudinal study establishing level II evidence of health related quality of life after types of immediate Latissimus Dorsi (LD) breast reconstruction . European Journal of Surgical Oncology vol. 35 , ( 11 )

Kirby AM, Evans PM, Haviland JS, Yarnold JR ( 2009 ) . 5124 Left anterior descending coronary artery (LAD) doses from breast radiotherapy: is prone treatment positioning beneficial? . European Journal of Cancer Supplements . vol. 7 ,

Gujral DM, Sumo G, Owen JR, Ashton A, Bliss JM, Haviland JS, Yarnold JR ( 2009 ) . 5126 Ipsilateral breast tumour relapse: local recurrence versus new primary and the effect of whole breast radiotherapy on the rate of new primaries . European Journal of Cancer Supplements . vol. 7 ,

Brunt AM, Sydenham M, Bliss J, Coles C, Gothard L, Harnett A, Haviland J, Syndikus I et al. ( 2009 ) . 7LBA A 5-fraction regimen of adjuvant radiotherapy for women with early breast cancer: first analysis of the randomised UK FAST trial (ISRCTN62488883, CRUKE/04/015) . European Journal of Cancer Supplements . vol. 7 ,

CORNER J, YARDLEY J, MAHER EJ, ROFFE L, YOUNG T, MASLIN‐PROTHERO S, GWILLIAM C, HAVILAND J et al. ( 2009 ) . Patterns of complementary and alternative medicine use among patients undergoing cancer treatment . European Journal of Cancer Care vol. 18 , ( 3 ) 271 - 279 .

FENLON DR, CORNER JL, HAVILAND J ( 2009 ) . Menopausal hot flushes after breast cancer . European Journal of Cancer Care vol. 18 , ( 2 ) 140 - 148 .

Miles EA, Venables K, Hoskin PJ, Aird EGA, Group OBOTSTM ( 2009 ) . Dosimetry and field matching for radiotherapy to the breast and supraclavicular fossa . Radiotherapy and Oncology vol. 91 , ( 1 ) 42 - 48 .

Kirby AM, Evans PM, Haviland J, Yarnold JR ( 2009 ) . Left Anterior Descending Coronary Artery (LAD) Doses from Breast Radiotherapy: is Prone Treatment Beneficial? . CLINICAL ONCOLOGY . vol. 21 , 251 - 252 .

Martin S, Mannino M, Rostom A, Tait D, Donovan E, Eagle S, Haviland J, Yarnold J ( 2008 ) . Acute Toxicity and 2-year Adverse Effects of 30 Gy in Five Fractions over 15 Days to Whole Breast after Local Excision of Early Breast Cancer . Clinical Oncology vol. 20 , ( 7 ) 502 - 505 .

Haviland JS, Ashton A, Broad B, Gothard L, Owen JR, Tait D, Sydenham MA, Yarnold JR et al. ( 2008 ) . Evaluation of a Method for Grading Late Photographic Change in Breast Appearance after Radiotherapy for Early Breast Cancer . Clinical Oncology vol. 20 , ( 7 ) 497 - 501 .

Fenlon DR, Corner JL, Haviland JS ( 2008 ) . A Randomized Controlled Trial of Relaxation Training to Reduce Hot Flashes in Women with Primary Breast Cancer . Journal of Pain and Symptom Management vol. 35 , ( 4 ) 397 - 405 .

Mills J, Sumo G, Haviland J, Bliss JM, Hopwood P ( 2008 ) . Age, clinical and psychological associations with fatigue following radiotherapy for early breast cancer – Results from 2208 women in the UK Standardisation of Breast Radiotherapy Trials (START) on behalf of the START Trial Management Group . European Journal of Cancer Supplements . vol. 6 ,

Sumo G, Haviland J, Mills J, Bliss JM, Yarnold J, Hopwood P, group. ROBOTSTM ( 2008 ) . The effects of radiotherapy on normal tissues in early breast cancer: results of the UK standardisation of breast radiotherapy (START) trials . European Journal of Cancer Supplements . vol. 6 ,

Bentzen SM, Agrawal RK, Aird EGA, Barrett JM, Barrett-Lee PJ, Bliss JM, Brown J, Dewar JA et al. ( 2008 ) . The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial . The Lancet Oncology vol. 9 , ( 4 ) 331 - 341 .

Bentzen SM, Agrawal RK, Aird EGA, Barrett JM, Barrett-Lee PJ, Bentzen SM, Bliss JM, Brown J et al. ( 2008 ) . The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial . The Lancet vol. 371 , ( 9618 ) 1098 - 1107 .

Christakis J, Vavatsi N, Hassapopoulou H, Angeloudi M, Papadopoulou M, Loukopoulos D, Morris JS, Serjeant BE et al. ( 2008 ) . A comparison of sickle cell syndromes in Northern Greece . British Journal of Haematology vol. 77 , ( 3 ) 386 - 391 .

Padmos MA, Sackey K, Roberts GT, Kulozik A, Bail S, Morris JS, Serjeant BE, Serjeant GR ( 2008 ) . Two different forms of homozygous sickle cell disease occur in Saudi Arabia . British Journal of Haematology vol. 79 , ( 1 ) 93 - 98 .

Hopwood P, Haviland J, Mills J, Sumo G, Bliss JM ( 2008 ) . Corrigendum to “The impact of age and clinical factors on quality of life in early breast cancer: An analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial)” [Breast 16 (2007) 241–251] . The Breast vol. 17 , ( 1 )

Mills J, Sumo G, Haviland J, Bliss J, Hopwood P ( 2008 ) . Age, clinical and psychological associations with fatigue following radiotherapy for early breast cancer: Results from 2208 women in the UK standardisation of breast radiotherapy trials (START) reported on behalf of the START trial management group . PSYCHO-ONCOLOGY . vol. 17 , S37 - S38 .

Hopwood P, Sumo G, Mills J, Haviland J, Bliss J, Yarnold J, Group THESTM ( 2007 ) . 1100 POSTER Body image and breast symptoms in early breast cancer: first results of the UK standardisation of breast radiotherapy (START) trials . European Journal of Cancer Supplements vol. 5 , ( 4 )

Hopwood P, Sumo G, Mills J, Haviland J, Bliss JM ( 2007 ) . 1106 POSTER Prevalence, patterns and predictors of mood disorders in early breast cancer: results from 2208 women in the UK Standardisation of Breast Radiotherapy Trial (START) . European Journal of Cancer Supplements . vol. 5 ,

Mills J, Haviland J, Hopwood P, Bliss JM, Brown J ( 2007 ) . 1118 POSTER Return to paid and unpaid activities after radiotherapy for early stage breast cancer . European Journal of Cancer Supplements . vol. 5 ,

Owen JR, Haviland J, Agrawal R, Bliss J, Dewar J, Hopwood P, Magee B, Sydenham M et al. ( 2007 ) . 2026 ORAL Results of the UK standardisation of breast radiotherapy (START) trials testing hypofractionation for early breast cancer – on behalf of the START trials centres . European Journal of Cancer Supplements . vol. 5 , 191 - 192 .

Lawton PA, Aird E, Bliss J, Haviland J, Magee B, Sydenham M, Venables K, Yarnold J et al. ( 2007 ) . 2037 POSTER The effect of hypofractionation and radiation dosimetry on the incidence of symptomatic rib fractures in women treated with radiotherapy for early breast cancer in the UK standardisation of breast radiotherapy (START) Trials . European Journal of Cancer Supplements . vol. 5 ,

Sydenham M, Haviland J, Bliss J, Gothard L, Tait D, Yarnold J ( 2007 ) . 2081 POSTER Scoring photographic assessment of normal tissue effects after radiotherapy for early breast cancer – a comparison of two different methods . European Journal of Cancer Supplements . vol. 5 ,

Dewar JA, Haviland JS, Agrawal RK, Bliss JM, Hopwood P, Magee B, Owen JR, Sydenham MA et al. ( 2007 ) . Hypofractionation for early breast cancer: First results of the UK standardization of breast radiotherapy (START) trials . Journal of Clinical Oncology vol. 25 , ( 18_suppl ) lba518 - lba518 .

Sydenham M, Haviland J, Gothard L, Tait D, Yarnold J ( 2007 ) . Scoring Photographic Assessment of Normal Tissue Effects after Radiotherapy for Early Breast Cancer . Clinical Oncology . vol. 19 ,

Hopwood P, Haviland J, Mills J, Sumo G, Bliss JM ( 2007 ) . The impact of age and clinical factors on quality of life in early breast cancer: An analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial) . The Breast vol. 16 , ( 3 ) 241 - 251 .

Hopwood R, Sumo G, Mills J, Haviland J, Bliss J, Yannold J ( 2007 ) . Body image and breast symptoms in early breast cancer: first results of the UK standardisation of breast radiotherapy (START) trials . EJC SUPPLEMENTS . vol. 5 , 141 - 141 .

Mills J, Haviland J, Brown J, Hopwood P, Bliss JM ( 2007 ) . How soon do patients return to paid and unpaid activities after radiotherapy treatment for early stage breast cancer? . PSYCHO-ONCOLOGY . vol. 16 , S145 - S145 .

Mills J, Bliss JM, Hopwood P ( 2007 ) . How to generate quality in 'Quality of life' studies: Experiences from a radiotherapy trial for early stage breast cancer (START trial) . PSYCHO-ONCOLOGY . vol. 16 , S145 - S146 .

Dewar JA, Haviland JS, Agrawal RK, Bliss JM, Hopwood P, Magee B, Owen JR, Sydenham MA et al. ( 2007 ) . Hypofractionation for early breast cancer: First results of the UK standardization of breast radiotherapy (START) trials . JOURNAL OF CLINICAL ONCOLOGY . vol. 25 ,

Hopwood P, Haviland J, Sumo G, Mills J, Bliss JM, Yarnold J ( 2007 ) . Patient rated breast symptoms and body image in early breast cancer: first results of the UK standardisation of breast radiotherapy (START) trials . BREAST CANCER RESEARCH AND TREATMENT . vol. 106 , S199 - S200 .

Yarnold JR, Bentzen SM, Haviland J, Owen JR ( 2006 ) . Dose and fractionation regimens for breast cancer – Authors' reply . The Lancet Oncology vol. 7 , ( 8 ) 619 - 620 .

Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J, Haviland J, Bentzen SM et al. ( 2006 ) . Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial . The Lancet Oncology vol. 7 , ( 6 ) 467 - 471 .

Martin S, Donovan E, Eagle S, Gothard L, Haviland J, Rostom A, Tait D, Yarnold J ( 2006 ) . Acute normal tissue reaction (moist desquamation) in patients with early breast cancer treated with 30Gy in 6 fractions over 15 days: Results of a pilot study . RADIOTHERAPY AND ONCOLOGY . vol. 81 , S276 - S277 .

Haviland J, Ashton A, Bliss J, Homewood J, Hanson J, Owen JR, Yarnold J ( 2006 ) . Is there an association between late normal tissue response and tumour control after local tumour excision and radiotherapy for early breast cancer? . RADIOTHERAPY AND ONCOLOGY . vol. 81 , S286 - S287 .

Acolet D, Elbourne D, McIntosh N, Weindling M, Korkodilos M, Haviland J, Modder J, Macintosh M ( 2005 ) . Project 27/28: Inquiry Into Quality of Neonatal Care and Its Effect on the Survival of Infants Who Were Born at 27 and 28 Weeks in England, Wales, and Northern Ireland . Pediatrics vol. 116 , ( 6 ) 1457 - 1465 .

Morris JS, Dunn DT, Poddar D, Serjeant GR ( 2005 ) . Haematological risk factors for pregnancy outcome in Jamaican women with homozygous sickle cell disease . BJOG An International Journal of Obstetrics & Gynaecology vol. 101 , ( 9 ) 770 - 773 .

Watson M, Homewood J, Haviland J, Bliss JM ( 2005 ) . Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort . European Journal of Cancer vol. 41 , ( 12 ) 1710 - 1714 .

Venables K, Miles EA, Hoskin PJ, Aird EGA ( 2005 ) . Verification Films: A Study of the Daily and Weekly Reproducibility of Breast Patient Set-up in the START Trial . Clinical Oncology vol. 17 , ( 5 ) 337 - 342 .

Coombes RC, Howell A, Emson M, Peckitt C, Gallagher C, Bengala C, Tres A, Welch R et al. ( 2005 ) . High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trial . Annals of Oncology vol. 16 , ( 5 ) 726 - 734 .

Andreassen CN, Alsner J, Overgaard J, Herskind C, Haviland J, Owen R, Homewood J, Bliss J et al. ( 2005 ) . TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer . Radiotherapy and Oncology vol. 75 , ( 1 ) 18 - 21 .

Yarnold J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J, Haviland J, Bentzen S et al. ( 2005 ) . Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial . Radiotherapy and Oncology vol. 75 , ( 1 ) 9 - 17 .

Mills J, Brown J, Haviland J, Bliss J ( 2005 ) . How soon do patients return to paid and unpaid activities after radiotherapy treatment for early stage breast cancer? . PSYCHO-ONCOLOGY . vol. 14 , 1090 - 1091 .

BAILEY C, CORNER J, ADDINGTON‐HALL J, KUMAR D, HAVILAND J ( 2004 ) . Older patients’ experiences of treatment for colorectal cancer: an analysis of functional status and service use . European Journal of Cancer Care vol. 13 , ( 5 ) 483 - 493 .

Venables K, Miles EA, Deighton A, Aird EGA, Hoskin PJ ( 2004 ) . Irradiation of the heart during tangential breast treatment: a study within the START trial . British Journal of Radiology vol. 77 , ( 914 ) 137 - 142 .

Johnston SRD, Gumbrell LA, Evans TRJ, Coleman RE, Smith IE, Twelves CJ, Soukop M, Rea DW et al. ( 2004 ) . A Cancer Research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen . Cancer Chemotherapy and Pharmacology vol. 53 , ( 4 ) 341 - 348 .

Yarnold J, Bundred N, Dewar J, George W, Haviland J, Dawson C, Bliss J ( 2004 ) . DCIS II trial: a randomised trial testing observation (no radiotherapy) against radiotherapy in women with low-risk completely excised oestrogen receptor (ER) positive ductal carcinoma in situ (DCIS) of the breast on adjuvant endocrine therapy . RADIOTHERAPY AND ONCOLOGY . vol. 73 , S34 - S35 .

Yarnold J, Ashton A, Bliss J, Broad B, Homewood J, Jackson C, Regan J, Haviland J et al. ( 2004 ) . Radiotherapy fractionation: Results of a pilot study to the NCRI standardisation of radiotherapy (START) trial . BRITISH JOURNAL OF CANCER . vol. 91 , S19 - S19 .

Bailey C, Corner J, Addington-Hall J, Kumar D, Haviland J ( 2003 ) . 1105 Older patients' experiences of colorectal cancer: functional status and service use following treatment . European Journal of Cancer Supplements vol. 1 , ( 5 )

BAILEY C, CORNER J, ADDINGTON‐HALL J, KUMAR D, NELSON M, HAVILAND J ( 2003 ) . Treatment decisions in older patients with colorectal cancer: the role of age and multidimensional function . European Journal of Cancer Care vol. 12 , ( 3 ) 257 - 262 .

Watson M, Davidson-Homewood J, Haviland J, Bliss J ( 2003 ) . Psychological coping and cancer . The BMJ vol. 326 , ( 7389 )

Watson M, Davidson-Homewood J, Haviland J, Bliss J, Mitchell A, Kumar M, Petticrew M, Bell R et al. ( 2003 ) . Psychological coping and cancer (multiple letters)[2] . British Medical Journal vol. 326 , ( 7389 ) 598 - 599 .

Corner J, Halliday D, Haviland J, Douglas H, Bath P, Clark D, Normand C, Beech N et al. ( 2003 ) . Exploring nursing outcomes for patients with advanced cancer following intervention by Macmillan specialist palliative care nurses . Journal of Advanced Nursing vol. 41 , ( 6 ) 561 - 574 .

Haviland J, Bliss J, Sydenham M, Cruickshank C, Yarnold J ( 2003 ) . Evaluation of the START (standardisation of breast radiotherapy) trial . CONTROLLED CLINICAL TRIALS . vol. 24 , 155S - 155S .

( 2003 ) . Nurse led follow-up may be as acceptable and effective as conventional follow-up for people with lung cancer . Evidence-based Healthcare and Public Health vol. 7 , ( 2 ) 57 - 59 .

Moore S, Corner J, Haviland J, Wells M, Salmon E, Normand C, Brada M, O'Brien M et al. ( 2002 ) . Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial . The BMJ vol. 325 , ( 7373 )

Ward E, Spruyt A, Fox L, Johnson L, Wong E, Behets F, Figueroa JP, Morris J ( 2001 ) . Strategies for Detection of Sexually Transmitted Infection among Family Planning Clients in Jamaica . International Perspectives on Sexual and Reproductive Health vol. 27 , ( 4 )

Watson M, Haviland J, Davidson J, Bliss J ( 2000 ) . Fighting spirit in patients with cancer . The Lancet vol. 355 , ( 9206 )

Watson M, Haviland J, Davidson-Holmwood J, Bliss J ( 2000 ) . Psychological response and breast cancer survival: are they linked and how? . PSYCHO-ONCOLOGY . vol. 9 , S12 - S12 .

Watson M, Davidson J, Haviland J ( 2000 ) . Psychological response and survival in breast cancer . The Lancet vol. 355 , ( 9201 )

Watson M, Haviland J, Greer S, Davidson J, Bliss J ( 1999 ) . Influence of psychological response on survival in breast cancer: a population-based cohort study . The Lancet vol. 354 , ( 9187 ) 1331 - 1336 .

Watson M, Haviland JS, Greer S, Davidson J, Bliss JM ( 1998 ) . Does psychological response influence survival from breast cancer? . European Journal of Cancer vol. 34 ,

Hawken MP, Meme HK, Elliott LC, Chakaya JM, Morris JS, Githui WA, Juma ES, Odhiambo JA et al. ( 1997 ) . Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults . AIDS vol. 11 , ( 7 ) 875 - 882 .

Hawken MP, Ojoo JCO, Morris JS, Kariuki EW, Githui WA, Juma ES, Gathua SN, Kimari JN et al. ( 1996 ) . No increased prevalence of adrenocortical insufficiency in human immunodeficiency virus-associated tuberculosis . Tuberculosis vol. 77 , ( 5 ) 444 - 448 .

Egan AF, Chappel JA, Burghaus PA, Morris JS, McBride JS, Holder AA, Kaslow DC, Riley EM ( 1995 ) . Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum . Infection and Immunity vol. 63 , ( 2 ) 456 - 466 .

Whittle H, Morris J, Todd J, Corrah T, Sabally S, Bangali J, Ngom PT, Rolfe M et al. ( 1994 ) . HIV-2-infected patients survive longer than HIV-1 -infected patients . AIDS vol. 8 , ( 11 ) 1617 - 1620 .

Bailey K, Morris JS, Thomas P, Serjeant GR ( 1992 ) . Fetal haemoglobin and early manifestations of homozygous sickle cell disease . Archives of Disease in Childhood vol. 67 , ( 4 )

Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR ( 1992 ) . Stroke in a cohort of patients with homozygous sickle cell disease . The Journal of Pediatrics vol. 120 , ( 3 ) 360 - 366 .

Christakis J, Hassapopoulou H, Papadopoulou M, Mandraveli K, Vavatsi N, Loukopoulos D, Morris JS, Serjeant BE et al. ( 1990 ) . Comparison of homozygous sickle cell disease in Northern Greece and Jamaica . The Lancet vol. 335 , ( 8690 ) 637 - 640 .

Readett DR, Morris JS, Serjeant GR ( 1990 ) . Nocturnal enuresis in sickle cell haemoglobinopathies . Archives of Disease in Childhood vol. 65 , ( 3 )

Fox PD, Dunn DT, Morris JS, Serjeant GR ( 1990 ) . Risk factors for proliferative sickle retinopathy . British Journal of Ophthalmology vol. 74 , ( 3 )